Research highlights health risks posed by 2,6-DHNPs in drinking water

2,6-DHNPs, a group of disinfection byproducts (DBPs), are raising alarm bells for public health. These bad actors in the water world are tougher and more toxic than many other pollutants, making it hard for typical water cleaning methods to get rid of them. They pack a powerful punch, being significantly more harmful to marine life and cells than similar pollutants. Found in places like sewage, swimming pools, and our drinking taps, 2,6-DHNPs are everywhere, signaling a pressing need for better ways to clean our water and keep us safe.

A new study (DOI: 10.1016/j.eehl.2024.02.004), published in Eco-Environment & Health on 4 March 2024, has uncovered the severe cardiotoxic impacts 2,6-DHNPs have on zebrafish embryos, serving as a model for potential human health risks.

2,6-DHNPs, a group of DBPs resistant to traditional water purification methods like boiling and filtration. These DBPs pose a significant risk, showing a toxicity level 248 times higher than the known regulated DBPs, dichloroacetic acid, in zebrafish embryos. Using zebrafish as a biological model due to their genetic similarity to humans the study meticulously detailed how these emerging contaminants wreak havoc on cardiac health. The zebrafish embryos exposed to 2,6-DHNPs suffered from severe heart damage characterized by increased production of harmful reactive oxygen species, cell death (apoptosis), and disrupted heart development.

The study revealed that 2,6-DCNP and 2,6-DBNP, two types of DBPs, exhibited significant resistance to removal in drinking water treatment plants. Boiling and filtration were found to be the most effective household water treatment methods, reducing 2,6-DCNP and 2,6-DBNP levels by 47% and 52%, respectively. Exposure to 2,6-DHNPs caused heart failure in zebrafish embryos through increased production of harmful reactive oxygen species (ROS) and delayed heart development. Notably, the antioxidant N-acetyl-L-cysteine was able to mitigate the cardiotoxic effects induced by 2,6-DHNPs.

Dr. Hongjie Sun, a leading researcher in the study, stated, "The cardiotoxic potential of 2,6-DHNPs at low concentrations significantly challenges our current understanding of water safety and highlights the need for urgent reassessment of drinking water treatment methods."

Dr. Peng Gao, the corresponding author, added, "Our findings underscore the importance of evaluating the health impacts of disinfection byproducts that may form during water treatment and being resistant to household treatment. We need to prioritize the development of advanced water purification technologies to effectively remove these concerning pollutants and safeguard public health.

This research underscores a critical environmental and public health issue: the contaminants that survive water treatment processes can lead to severe health outcomes in exposed organisms, hinting at the possible public health risks faced by these persistent waterborne chemicals.

Source:
Journal reference:

Sun, H., et al. (2024). Dihalogenated nitrophenols in drinking water: Prevalence, resistance to household treatment, and cardiotoxic impact on zebrafish embryo. Eco-Environment & Health. doi.org/10.1016/j.eehl.2024.02.004

Comments

  1. Donald Mcdonell Donald Mcdonell United States says:

    What are the disinfectants that produce.
    2,6-DHNPs as by product? This should have been included early in the article.

  2. Jeanine Ireland Jeanine Ireland United States says:

    I see. Maybe that's causing all those pesky heart problems we've been seeing the last few years because it certainly could never be that mRNA gene therapy shots they forced on everyone. It's most certainly tap water.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH awards grant to study how dilated cardiomyopathy progresses to heart failure